Costs of opioid overdose education and naloxone distribution in New York City

References

• U.S. Department of Health and Human Services. ASPE Issue Brief: Opioid Abuse in the U.S. and HHS Actions to Address Opioid-Drug Related Overdoses and Deaths. Washington, DC: HHS; 2015.
   Google Scholar
• U.S. Department of Health and Human Services (HHS). Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: HHS; 2016.
   Google Scholar
• Rees DI, Sabia JJ, Argys LM, Dave D, Latshaw J. With a little help from my friends: the effects of good samaritan and naloxone access laws on opioid-related deaths. J Law Econ. 2019;62(1):1–27.
   Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• Nolan MM, Tuzon E, Paone D. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2018. New York, NY: New York City Department of Health and Mental Hygiene; 2019.
   Google Scholar
• The City of New York Office of the Mayor. HealingNYC: Preventing Overdoses, Saving Lives. https://www1.nyc.gov/assets/home/downloads/pdf/reports/2017/HealingNYC-Report.pdf. Published 2017. Accessed September 20, 2019.
   Google Scholar
• Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2016;111(5):883–891.
   PubMed Web of Science ®Google Scholar
• Cipriano LE, Zaric GS. Cost-effectiveness of naloxone kits in secondary schools. Drug Alcohol Depend. 2018;192:352–361.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1–9.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ. 2013;16(8):1051–1060.
   PubMedGoogle Scholar
• Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the United Kingdom. Value Health. 2018;21(4):407–415.
   PubMed Web of Science ®Google Scholar
• Naumann RB, Durrance CP, Ranapurwala SI, et al. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend. 2019;204:107536.
   PubMed Web of Science ®Google Scholar
• Townsend T, Blostein F, Doan T, Madson-Olson S, Galecki P, Hutton DW. Cost-effectiveness analysis of alternative naloxone distribution strategies: first responder and lay distribution in the United States. Int J Drug Policy. 2020;75:102536.
   PubMed Web of Science ®Google Scholar
• Uyei J, Fiellin DA, Buchelli M, Rodriguez-Santana R, Braithwaite RS. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study. Lancet Public Health. 2017;2(3):e133–e140.
   PubMed Web of Science ®Google Scholar
• Gupta R, Shah ND, Ross JS. The rising price of naloxone - risks to efforts to stem overdose deaths. N Engl J Med. 2016;375(23):2213–2215.
   PubMed Web of Science ®Google Scholar
• Kerensky T, Walley AY. Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know. Addict Sci Clin Pract. 2017;12(1):4.
   PubMedGoogle Scholar
• Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. Morb Mort Weekly Rep. 2015;64(23):631–635.
   PubMed Web of Science ®Google Scholar
• Winstanley EL, Clark A, Feinberg J, Wilder CM. Barriers to implementation of opioid overdose prevention programs in Ohio. Subst Abus. 2016;37(1):42–46.
   PubMed Web of Science ®Google Scholar
• SafeProject. State Naloxone Access Rules and Resources. https://www.safeproject.us/naloxone-awareness-project/state-rules/. Published 2020. Accessed February 14, 2020.
   Google Scholar
• U.S. Bureau of Labor Statistics. Employer Costs for Employee Compensation Historical Listing. https://www.bls.gov/ncs/ect/sp/ececqrtn.pdf. Published 2017. Accessed April 1, 2017.
   Google Scholar
• New York City Department of Health and Mental Hygiene. Naloxone Recipient Form (NRF). http://clinicalmonster.com/wp-content/uploads/2018/07/English_NRF-OOPP_052018-55054-Activated-VersiForm.pdf. Published 2018. Accessed March 21, 2019.
   Google Scholar
• Dolatshahi J, Maldjian L, Welch A, Fulmer C, Winkelstein E. Tracking community naloxone dispensing: part of a strategy to reduce overdose deaths. J Public Health Inform. 2019;11(1):e445.
   Google Scholar
• Teixeira PA, Bresnahan MP, Laraque F, et al. Telementoring of primary care providers delivering hepatitis C treatment in New York City: results from Project INSPIRE. Learn Health Sys. 2018;2(3):e10056.
   PubMed Web of Science ®Google Scholar
• Oldfield BJ, Tetrault JM, Wilkins KM, Edelman EJ, Capurso NA. Opioid overdose prevention education for medical students: adopting harm reduction into mandatory clerkship curricula. Subst Abus. 2020;41(1):29–34.
   PubMed Web of Science ®Google Scholar
• Devries J, Rafie S, Polston G. Implementing an overdose education and naloxone distribution program in a health system. J Am Pharm Assoc. 2017;57(2S):S154–S160.
   Google Scholar
• Oliva EM, Christopher MLD, Wells D, et al. Opioid overdose education and naloxone distribution: development of the Veterans Health Administration’s national program. J Am Pharm Assoc. 2017;57(2S):S168–S179.
   Google Scholar
• Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153–163.
   PubMed Web of Science ®Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240–253.
   PubMed Web of Science ®Google Scholar
• Spelman JF, Peglow S, Schwartz AR, Burgo-Black L, McNamara K, Becker WC. Group visits for overdose education and naloxone distribution in primary care: a pilot quality improvement initiative. Pain Med. 2017;18(12):2325–2330.
   PubMed Web of Science ®Google Scholar
• Wenger LD, Showalter D, Lambdin B, et al. Overdose education and naloxone distribution in the San Francisco County Jail. J Correct Health Care. 2019;25(4):394–404.
   PubMed Web of Science ®Google Scholar